|Articles|February 9, 2022
- Pharmaceutical Executive-02-01-2022
- Volume 42
- Issue 2
Pharmaceutical Executive, February 2022 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive February 2022 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 4 years ago
As Change Continues, Are You Digitally Fit For the Future?about 4 years ago
Ready for Pharma’s Next Chapterabout 4 years ago
The Tech Perspective: Coordinating a Plan of Engagementabout 4 years ago
The Importance of Culturally Inclusive and Relevant Marketingabout 4 years ago
Messaging Makeoverabout 4 years ago
Ethics of Antibioticsabout 4 years ago
What’s Up in Biotech These Days? Not Much, Unfortunatelyabout 4 years ago
Planning for Second to Market in Orphan Disease Spaceabout 4 years ago
AI and Analytics Appear Ready to Surge in Sales and Marketingabout 4 years ago
It’s Time for Companies To See Employees as Full-Time PeopleNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Influence of Trump Rx in Pharmacy Benefit Managers, Retail Pharmacies, and Digital Health Platforms
2
Leading in the Psychedelic Space: Q&A with Tarek Rabah
3
Boehringer Ingelheim Acquires Exclusive License from Sitryx Therapeutics for Preclinical Small Molecule Program
4
Bringing HIV Prevention DTC: Q&A with Ashley Gildea
5

